These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15558760)

  • 1. New bifurcation stenting technique: shunt stenting.
    Prasan AM; Pitney MR; Ramsay D; Jepson NS; Friedman D; Taylor D; Giles RW
    Catheter Cardiovasc Interv; 2004 Dec; 63(4):474-81. PubMed ID: 15558760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results.
    Orlic D; Bonizzoni E; Stankovic G; Airoldi F; Chieffo A; Corvaja N; Sangiorgi G; Ferraro M; Briguori C; Montorfano M; Carlino M; Colombo A
    J Am Coll Cardiol; 2004 Apr; 43(7):1154-60. PubMed ID: 15063422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease.
    Chu WW; Rha SW; Kuchulakanti PK; Cheneau E; Torguson R; Pakala R; Pinnow EE; Pichard AD; Satler LF; Kent KM; Lindsay J; Waksman R
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):473-7. PubMed ID: 15973656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent fracture associated with drug-eluting stents: clinical characteristics and implications.
    Lee MS; Jurewitz D; Aragon J; Forrester J; Makkar RR; Kar S
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):387-94. PubMed ID: 17195203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
    Aoki J; Nakazawa G; Tanabe K; Hoye A; Yamamoto H; Nakayama T; Onuma Y; Higashikuni Y; Otsuki S; Yagishita A; Yachi S; Nakajima H; Hara K
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):380-6. PubMed ID: 17195199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus-eluting stent in chronic total occlusion: the SICTO study.
    Lotan C; Almagor Y; Kuiper K; Suttorp MJ; Wijns W
    J Interv Cardiol; 2006 Aug; 19(4):307-12. PubMed ID: 16881976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acute and long-term results and underlying mechanisms from sirolimus-eluting stent implantation for the treatment of in-stent restenosis and recurrent in-stent restenosis in patients in whom intracoronary radiation failed as assessed by intravascular ultrasound.
    Schiele TM; Rieber J; König A; Leibig M; Erhard I; Theisen K; Siebert U; Klauss V
    Am J Cardiol; 2004 Oct; 94(7):917-21. PubMed ID: 15464677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
    Vijayakumar M; Rodriguez Granillo GA; Lemos PA; Aoki J; Hoye A; Ong AT; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Serruys PW
    J Invasive Cardiol; 2005 Jan; 17(1):10-2. PubMed ID: 15640531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.
    Kim JY; Ko YG; Shim CY; Park S; Hwang KC; Choi D; Jang Y; Chung N; Shim WH; Cho SY
    Am J Cardiol; 2005 Nov; 96(10):1384-8. PubMed ID: 16275183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy).
    Ortolani P; Ardissino D; Cavallini C; Bramucci E; Indolfi C; Aquilina M; Marzocchi A
    Am J Cardiol; 2005 Nov; 96(10):1393-8. PubMed ID: 16275185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
    Aziz S; Ramsdale DR
    J Invasive Cardiol; 2005 Jan; 17(1):13. PubMed ID: 15640532
    [No Abstract]   [Full Text] [Related]  

  • 13. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.
    Ong AT; Hoye A; Aoki J; van Mieghem CA; Rodriguez Granillo GA; Sonnenschein K; Regar E; McFadden EP; Sianos G; van der Giessen WJ; de Jaegere PP; de Feyter P; van Domburg RT; Serruys PW
    J Am Coll Cardiol; 2005 Mar; 45(6):947-53. PubMed ID: 15766834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease.
    Kornowski R; Vaknin-Assa H; Assali A; Fuchs S
    Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stents.
    Galassi AR; Tomasello SD; Capodanno D; Barrano G; Ussia GP; Tamburino C
    JACC Cardiovasc Interv; 2009 Mar; 2(3):185-94. PubMed ID: 19463424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifurcation disease: optimal angiographic result yet suboptimal long-term outcome.
    Pershad A
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):104. PubMed ID: 15343578
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
    Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
    Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
    Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW
    Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of sirolimus-eluting stents for treatment of ST-elevation acute myocardial infarction caused by left main coronary artery occlusion.
    Bush HS; Strong DE; Novaro GM
    Tex Heart Inst J; 2005; 32(3):421-3. PubMed ID: 16392234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.